This track will explore the latest breakthroughs in immunotherapy for various diseases, focusing on novel therapeutic strategies and their clinical applications. Participants will discuss the mechanisms of action and efficacy of emerging immunotherapeutic agents.

This session will delve into the pathophysiology of autoimmune diseases and the latest approaches to their management. Emphasis will be placed on innovative therapies and personalized medicine strategies.

This track will examine the immune response to infectious diseases, highlighting the role of immune modulation in treatment and prevention. Discussions will include vaccine development and the challenges posed by emerging pathogens.

This session will focus on the latest advancements in vaccine development, including novel platforms and adjuvants. Participants will discuss strategies for enhancing vaccine efficacy and addressing public health challenges.

This track will explore the role of immune biomarkers in diagnosing and monitoring diseases, as well as their potential in predicting treatment responses. Emphasis will be placed on the integration of biomarker discovery into clinical practice.

This session will investigate the mechanisms underlying immune regulation and tolerance, with a focus on their implications for therapy. Discussions will include the role of regulatory T cells and cytokines in maintaining immune homeostasis.